Diagnosing Alzheimer's disease involves a thorough assessment of cognitive functions, memory loss, behavioral changes, and daily functioning. Physicians typically start with a detailed medical history, neurological exams, and cognitive tests to evaluate memory, attention, language, and problem-solving skills. Brain imaging techniques like MRI or CT scans may be used to rule out other conditions and observe brain changes characteristic of Alzheimer's. Blood tests can help identify other possible causes of dementia-like symptoms.
Early diagnosis is crucial as it allows for prompt intervention and planning. However, Alzheimer's diagnosis remains challenging due to overlapping symptoms with other types of dementia and the gradual onset of cognitive decline. Ongoing research aims to develop more precise diagnostic tools, including biomarkers that detect brain changes associated with Alzheimer's before symptoms appear, enhancing early detection and intervention strategies.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States